Journal of Neuromuscular Diseases
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q2 | 68.9% | 1.066 | Q1 | 85.5% |
| 2024 | 3.4 | Q2 | 73.0% | 1.016 | Q2 | 84.6% |
| 2023 | 3.2 | Q2 | 58.9% | 0.949 | Q2 | 84.1% |
| 2022 | 3.3 | Q2 | 47.2% | 1.002 | Q1 | 86.3% |
| 2021 | 4.7 | Q2 | 67.0% | 1.054 | Q1 | 87.6% |
| 2020 | — | — | 1.366 | Q1 | 91.1% | |
| 2019 | — | — | 1.091 | Q2 | 87.5% | |
| 2018 | — | — | 0.992 | Q2 | 83.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2214-3602
ISSN
2214-3599
country
GBcoverage
2014-2026